Royal Bank of Canada’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206K | Sell |
44,353
-168,731
| -79% | -$784K | ﹤0.01% | 4792 |
|
|
2025
Q1 | $1.17M | Buy |
213,084
+198,984
| +1,411% | +$1.09M | ﹤0.01% | 3040 |
|
|
2024
Q4 | $48K | Sell |
14,100
-16,160
| -53% | -$55K | ﹤0.01% | 5236 |
|
|
2024
Q3 | $86K | Buy |
30,260
+2,913
| +11% | +$8.28K | ﹤0.01% | 4991 |
|
|
2024
Q2 | $61K | Buy |
27,347
+8,813
| +48% | +$19.7K | ﹤0.01% | 5171 |
|
|
2024
Q1 | $42K | Sell |
18,534
-36,770
| -66% | -$83.3K | ﹤0.01% | 5179 |
|
|
2023
Q4 | $131K | Buy |
55,304
+32,507
| +143% | +$77K | ﹤0.01% | 4915 |
|
|
2023
Q3 | $43K | Buy |
22,797
+8,015
| +54% | +$15.1K | ﹤0.01% | 5375 |
|
|
2023
Q2 | $39K | Buy |
14,782
+4,355
| +42% | +$11.5K | ﹤0.01% | 5452 |
|
|
2023
Q1 | $17K | Sell |
10,427
-7,830
| -43% | -$12.8K | ﹤0.01% | 5708 |
|
|
2022
Q4 | $24K | Buy |
18,257
+13,045
| +250% | +$17.1K | ﹤0.01% | 5767 |
|
|
2022
Q3 | $9K | Sell |
5,212
-9,133
| -64% | -$15.8K | ﹤0.01% | 5998 |
|
|
2022
Q2 | $22K | Sell |
14,345
-29,060
| -67% | -$44.6K | ﹤0.01% | 5609 |
|
|
2022
Q1 | $111K | Buy |
43,405
+23,305
| +116% | +$59.6K | ﹤0.01% | 5101 |
|
|
2021
Q4 | $59K | Sell |
20,100
-2,400
| -11% | -$7.05K | ﹤0.01% | 5751 |
|
|
2021
Q3 | $55K | Sell |
22,500
-264,303
| -92% | -$646K | ﹤0.01% | 5589 |
|
|
2021
Q2 | $1.17M | Buy |
286,803
+8,228
| +3% | +$33.5K | ﹤0.01% | 3133 |
|
|
2021
Q1 | $1.26M | Buy |
278,575
+67,920
| +32% | +$306K | ﹤0.01% | 2982 |
|
|
2020
Q4 | $1.04M | Buy |
210,655
+42,704
| +25% | +$210K | ﹤0.01% | 3002 |
|
|
2020
Q3 | $996K | Buy |
167,951
+26,037
| +18% | +$154K | ﹤0.01% | 2858 |
|
|
2020
Q2 | $377K | Sell |
141,914
-796
| -0.6% | -$2.12K | ﹤0.01% | 3567 |
|
|
2020
Q1 | $278K | Buy |
142,710
+98,807
| +225% | +$192K | ﹤0.01% | 3640 |
|
|
2019
Q4 | $309K | Buy |
43,903
+2,327
| +6% | +$16.4K | ﹤0.01% | 3748 |
|
|
2019
Q3 | $409K | Buy |
41,576
+21,603
| +108% | +$213K | ﹤0.01% | 3433 |
|
|
2019
Q2 | $228K | Sell |
19,973
-1,835
| -8% | -$20.9K | ﹤0.01% | 3842 |
|
|
2019
Q1 | $219K | Buy |
21,808
+14,340
| +192% | +$144K | ﹤0.01% | 3764 |
|
|
2018
Q4 | $127K | Buy |
7,468
+1,117
| +18% | +$19K | ﹤0.01% | 3988 |
|
|
2018
Q3 | $112K | Buy |
+6,351
| New | +$112K | ﹤0.01% | 4208 |
|